Yopi tech

4

up
more


About

YOPI’s system tracks online user's real Oxygen (VO2) consumption. (Read more)

Location: Israel

Start Date: June 2017

Team members: 4 (Read more)

Info

Technologies: RNN, React, Python

Category: Startup

Industry: Medical Device

Business Legal type: Limited Liability Company (LLC)

Raising: $1,500,000

Project Timeline

Jun 18, 2019

Raised Private equity 550$

Apr 13, 2021

Grant from IIA 1M$

Jun 14, 2022

FDA Device 1



Project Overview


                YOPI’s system tracks online user's real Oxygen (VO2) consumption.

                Wearables today ostensibly measure your physiological vitals as they tell you very little about your Cardio-Respiratory Fitness; so you may be “in shape” but about to die! As happened to Hemi, one of Yopi's founder. Only offline and expensive lab tests can detect and predict risky health conditions.
YOPI brings noninvasive measuring abilities from the lab to your wrist, based on sweat analysis. YOPI's system combines sophisticated biosensors and Artificial Intelligence algorithms that track in real-time the user health and wellness state, alert and guide the user accordingly.

YOPI’s system tracks online user's real Oxygen (VO2) consumption. (not saturation) and electrolytes such as Potassium (K  ) level, which are directly related to a wide range of physiological disorders e.g. heart health & wellness conditions.
            

Fund usage

Our recruitment is complete for the current round in which we have already received 1M from the Israel Innovation Authority.
We will use the budget for product finishing and distribution worldwide.
Minimum investment amount: $ 150K  

Users & Customers summary

Anyone who has an awareness to sports and health  

About

YOPI’s system tracks online user's real Oxygen (VO2) consumption. (Read more)

Location: Israel

Start Date: June 2017

Team members: 4 (Read more)

Info

Technologies: RNN, React, Python

Category: Startup

Industry: Medical Device

Tags:

Business Legal type: Limited Liability Company (LLC)

Stage: Series A

Funding: $1,500,000




The Team

Founder & CEO

Hemi Re'em

Founder & CSO

Dr. Menachem Genut

Medical Director

Anat Milman